Abstract
Bacteria utilize a wide variety of endogenous cell wall hydrolases, or autolysins, to remodel their cell walls during processes including cell division, biofilm formation, and programmed death. We here systematically investigate the composition of these enzymes in order to gain insights into their associated biological processes, potential ways to disrupt them via chemotherapeutics, and strategies by which they might be leveraged as recombinant antibacterial biotherapies. To do so, we developed LEDGOs (lytic enzyme domains grouped by organism), a pipeline to create and analyze databases of autolytic enzyme sequences, constituent domain annotations, and architectural patterns of multi-domain enzymes that integrate peptidoglycan binding and degrading functions. We applied LEDGOs to eight pathogenic bacteria, gram negatives Acinetobacter baumannii, Klebsiella pneumoniae, Neisseria gonorrhoeae, and Pseudomonas aeruginosa; and gram positives Clostridioides difficile, Enterococcus faecium, Staphylococcus aureus, and Streptococcus pneumoniae. Our analysis of the autolytic enzyme repertoires of these pathogens reveals commonalities and differences in their key domain building blocks and architectures, including correlations and preferred orders among domains in multi-domain enzymes, repetitions of homologous binding domains with potentially complementarity recognition modalities, and sequence similarity patterns indicative of potential divergence of functional specificity among related domains. We have further identified a variety of unannotated sequence regions within the lytic enzymes that may themselves contain new domains with important functions.
Highlights
Lysins, enzymes that degrade bacterial cell wall peptidoglycan, appear throughout the tree of life
The LEDGOs data collection pipeline, database, and analysis tool (Fig 1) enables multi-faceted characterization of the diversity of lytic enzyme domains and architectures in bacterial proteomes
The following sections summarize analyses and insights enabled by LEDGOs into the similarities and differences among the lytic enzyme domain repertoires commonly used by these bacteria, the architectural patterns connecting these building blocks in complete enzymes, and the amino acid sequences of the domains both overall and with respect to specific architectural contexts
Summary
Enzymes that degrade bacterial cell wall peptidoglycan, appear throughout the tree of life. Biotechnology has enabled the potent cell wall hydrolyzing functions of lysins to be leveraged in a wide range of applications. Lysins are being used as next-generation antibiotics [1,2,3,4], with numerous advantages over small molecule antibiotics including catalytic degradation of bacterial cell wall and resultant high potency and rapid onset of action. Examples of lysinbased therapeutics include human lysozyme [5], the bacteriocin lysostaphin in both wild-type [6] and deimmunized [7] forms, and the phage endolysin-based drugs named CF-301 [8] and SAL200 [9]. Applications of lysins include food safety and processing, where, for example, lysins are being studied as additives to eliminate pathogens including Staphylococcus, Listeria, and Clostridium in dairy and meat products [12,13,14,15]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.